420 related articles for article (PubMed ID: 12671884)
1. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
[TBL] [Abstract][Full Text] [Related]
2. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
3. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
[TBL] [Abstract][Full Text] [Related]
4. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
[TBL] [Abstract][Full Text] [Related]
6. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Eaton JE; Silveira MG; Pardi DS; Sinakos E; Kowdley KV; Luketic VA; Harrison ME; McCashland T; Befeler AS; Harnois D; Jorgensen R; Petz J; Lindor KD
Am J Gastroenterol; 2011 Sep; 106(9):1638-45. PubMed ID: 21556038
[TBL] [Abstract][Full Text] [Related]
7. Ursodiol for all?
Lee SD; Surawicz CM
Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
[No Abstract] [Full Text] [Related]
8. Ursodeoxycholic acid in patients with ulcerative colitis and primary sclerosing cholangitis for prevention of colon cancer: a meta-analysis.
Ashraf I; Choudhary A; Arif M; Matteson ML; Hammad HT; Puli SR; Bechtold ML
Indian J Gastroenterol; 2012 Apr; 31(2):69-74. PubMed ID: 22528343
[TBL] [Abstract][Full Text] [Related]
9. [Ulcerative colitis. Cancer prevention].
Schmiegel W; Pox C; Kroesen A
Z Gastroenterol; 2004 Sep; 42(9):1014-8. PubMed ID: 15455276
[No Abstract] [Full Text] [Related]
10. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
[TBL] [Abstract][Full Text] [Related]
11. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
12. Prevention of colon cancer with ursodiol in ulcerative colitis.
Kim HS
Inflamm Bowel Dis; 2001 Aug; 7(3):279-80. PubMed ID: 11515858
[No Abstract] [Full Text] [Related]
13. Ulcerative colitis and an abnormal cholangiogram.
Nguyen DL; Lazaridis KN
Cleve Clin J Med; 2011 May; 78(5):306-11. PubMed ID: 21536825
[No Abstract] [Full Text] [Related]
14. [Treatment of cholestatic liver diseases with ursodeoxycholic acid].
Boberg KM; Schrumpf E
Tidsskr Nor Laegeforen; 1997 Sep; 117(23):3370-3. PubMed ID: 9411890
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.
Färkkilä M; Karvonen AL; Nurmi H; Nuutinen H; Taavitsainen M; Pikkarainen P; Kärkkäinen P
Hepatology; 2004 Dec; 40(6):1379-86. PubMed ID: 15565569
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of colorectal cancer in ulcerative colitis.
Croog VJ; Ullman TA; Itzkowitz SH
Int J Colorectal Dis; 2003 Sep; 18(5):392-400. PubMed ID: 12904996
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention in ulcerative colitis: narrowing the gap between clinical practice and research.
Hawk ET; Viner JL
Ann Intern Med; 2001 Jan; 134(2):158-60. PubMed ID: 11177320
[No Abstract] [Full Text] [Related]
18. Mucin-producing carcinoma of the gallbladder associated with primary sclerosing cholangitis and ulcerative colitis.
Noda H; Chiba F; Toyama N; Konishi F
J Hepatobiliary Pancreat Surg; 2009; 16(1):83-5. PubMed ID: 19096754
[TBL] [Abstract][Full Text] [Related]
19. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
D'Haens GR; Lashner BA; Hanauer SB
Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
[TBL] [Abstract][Full Text] [Related]
20. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]